Articles

UP FRONT

• What is the Impact of CXL?

  By Sheraz M. Daya, MD, FACP, FACS, FRCS(Ed) - Chief Medical Editor

CATARACT SURGERY

• Special Considerations in Combined Cataract Surgery, DSAEK

  In combination with cataract removal, special care is needed for DSAEK, but the procedure does convey advantages.

  By W. Barry Lee, MD, FACS

COVER STORIES

• Biomechanical Changes in the Cornea After CXL

  The exact rate of connective tissue turnover is unknown.

  By Sally Hayes, PhD; and Keith M. Meek, PhD

• Does CXL Promote Artificial Aging?

  Because optimal corneal stiffness is unknown, mechanical changes following CXL may be excessive.

  By John Marshall, PhD, FRCPath, FRCOphth (Hon); and Nathaniel Knox-Cartwright, MA, MRCOphth

• Corneal Crosslinking for Different Corneal Diseases

  CXL is a promising development in ophthalmology for a number of conditions.

  By Aylin Kiliç Ertan, MD

• Is CXL an Alternative to Keratoplasty?

  CXL may postpone or prevent corneal transplantation in patients with progressive keratoconus or pellucid marginal degeneration.

  By Josef Reiter, MD

• CXL Indications and Patient Selection

  Patients must be told that the goal of treatment is not a refractive endpoint.

  By Richard Corkin, FCS (Ophth)SA, MRCOphth

• Treatment Protocols and Safety Issues

  Until safety is clearly established, only surgeons with knowledge of corneal wound healing should perform CXL—and only when the indication is clearly documented.

  By Farhad Hafezi, MD, PhD

• Transepithelial Tensioactive Mediated CXL

  By Roberto Pinelli, MD; and Hytham Ib El-Shawaf, MD

• CXL: Pediatric Experience

  In early onset keratoconus, CXL can prevent further loss of visual acuity.

  By Paolo Vinciguerra, MD; and Elena Albé, MD

• Sequential Versus Simultaneous CXL and Topography-Guided PRK

  Simultaneous treatment appears to provide superior rehabilitation of keratoconus.

  By A. John Kanellopoulos, MD

• Simultaneous Surface Ablation and CXL

  The authors have 2 years' experience with SimLC for keratoconus.

  By Arthur Cummings FRCS(Ed); and Eugene Y.J. Ng, MRCOphth

• PRK Followed by CXL

  This treatment improves functional vision and reduces the need for keratoplasty.

  By George D. Kymionis, MD, PhD; Georgios A. Kontadakis, MD, MSc; Dimitra M. Portaliou, MD; and Ioannis G. Pallikaris, MD, PhD

• ICRS Plus Crosslinking

  This combination results in greater improvements versus Keraring implantation alone.

  By Efekan Coskunseven, MD; Mirko R. Jankov II, MD, PhD; and George D. Kymionis, MD, PhD

• Surgical Visual Rehabilitation Techniques

  Surgeons share their preferences for visual rehab after CXL.

  By Jérôme C. Vryghem, MD, PhD; Efekan Coskunseven, MD; Albert Daxer, MD, PhD; A. John Kanellopoulos, MD; and Rudy M.M.A Nuijts, MD, PhD

TODAY'S PRACTICE

• Profitability: LASIK Versus Phakic IOLs

  The refractive surgery profitability model shows that as phakic IOL volume increases, so does the profitability margin.

  By Mark Rosenberg

DEPARTMENTS

• Innovations

• 5 Questions With Ghanta Madhavi, MD

  Dr. Madhavi is the Medical Director of Goutami Eye Institute in Andhra Pradesh, India.

  By Ghanta Madhavi, MD

View All News >